BridgeMD
New treatment option for Clinical High Risk for Psychosis (CHR)
Official title Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
ClinicalTrials.gov ID: NCT05968560
What this study is testing
- What it's testing
- This study aims to evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Psychosis typically emerges during late adolescence or early adulthood, significantly impacting long-term functioning.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 25
You may be able to join if
- Age 14-25
- Ability to participate in assessments and treatment in English
- Meets criteria for psychosis-risk on SIPS
- Stable on medications; no changes within 1 month prior to enrollment
- Identification of one "family member" with \>4 hours/week contact who is willing to participate ("Family member" can be any blood relative, spouse...
You likely can't join if
- Intellectual disability (IQ\<70)
- Medical condition known to cause psychosis
- Moderate or severe substance use disorder and active use within the past 30 days.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.